Zotarolimus-eluting Resolute Integrity versus everolimus-eluting Xience Xpedition stents in the management of very long ( > 30mm) de novo coronary artery stenosis

Procedural and clinical outcomes in patients with very long (>30mm) coronary lesions who underwent stent-based percutaneous coronary interventions are still unfavorable. Therefore, we compared the relative efficacy and safety of resolute zotarolimus-eluting stents (R-ZES) and Xpedition everolimus-eluting stents (X-EES) for patients with de novo very long coronary lesions.

Source: Cardiovascular Revascularization Medicine - December 13, 2016 Category: Cardiology Authors: Soumya Patra, Rabindra Nath Chakraborty, Arindam Pande, Suvro Banerjee, Manabhanjan Jena, Prakash Chandra Mandal, Swapan Kumar De, Aftab Khan, Sankha Suvro Das, Debashish Ghosh, Raja Nag Source Type: research